US-based BioVentrix has announced that placement of its Revivent-TC ventricular enhancement system, via Less Invasive Ventricular Enhancement (LIVE) procedure, has been successfully expanded to a second European clinical site. The ...
US-based BioVentrix has announced the successful completion of it 50th clinical case using the Revivent myocardial anchoring system in a 74-year-old male patient at the OLV Hospital in Aalst, Belgium. The case comes on the heels of other ...
Tags: BioVentrix, Revivent Technology
BioVentrix has launched a myocardial anchoring system for patients with ischemic cardiomyopathy. The new technology, Revivent, is designed for use in less invasive ventricular enhancement (LIVE) procedures to improve the function of ...